The Queen Alexandra Hospital in Cosham, Portsmouth, is one of the NHS hospitals serving the city of Portsmouth and the surrounding area. There are several small treatment outstations which have been opened to relieve the overload at the QA Hospital.

There are 997 beds in Queen Alexandra Hospital.

During the past decade, Queen Alexandra Hospital conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 20 clinical trials were completed, i.e. on average, 16.9% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 13 clinical trials were completed. i.e. 43.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Alexandra Hospital" #1 sponsor was "Portsmouth Hospitals NHS Trust" with 43 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "University College, London" with 8 trials sponsored, "University Hospital Southampton NHS Foundation Trust" with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Alexandra Hospital" #1 collaborator was "Portsmouth Hospitals NHS Trust" with 12 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 11 trials as a collaborator, "University of Portsmouth" with 10 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 6 trials as a collaborator and "The Leeds Teaching Hospitals NHS Trust" with 5 trials as a collaborator. Other collaborators include 272 different institutions and companies that were collaborators in the rest 216 trials.

According to Clinical.Site data, the most researched conditions in "Queen Alexandra Hospital" are "Asthma" (13 trials), "Breast Cancer" (7 trials), "Barrett Esophagus" (4 trials), "Heart Failure" (4 trials) and "Bladder Cancer" (3 trials). Many other conditions were trialed in "Queen Alexandra Hospital" in a lesser frequency.

Most popular intervention types in "Queen Alexandra Hospital" are "Drug" (64 trials), "Device" (30 trials), "Other" (23 trials), "Procedure" (22 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bortezomib" (3 trials), "quality-of-life assessment" (3 trials), "Bendamustine" (2 trials) and "Cartiva" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Alexandra Hospital" are 157 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Queen Alexandra Hospital". 1 are not yet recruiting, 20 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 103 completed trials in Queen Alexandra Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Alexandra Hospital, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 42 trials that are defined as “Not Applicable".

Queen Alexandra Hospital has several departments that took part in Clinical trials: "Queen Alexandra Hospital; Portsmouth Haematology & Oncology Centre, Level B" - 4 trials